Free Trial

Roger Yates Acquires 10,000 Shares of The Biotech Growth Trust PLC (LON:BIOG) Stock

The Biotech Growth Trust logo with Financial Services background

The Biotech Growth Trust PLC (LON:BIOG - Get Free Report) insider Roger Yates acquired 10,000 shares of the company's stock in a transaction dated Wednesday, June 4th. The shares were bought at an average cost of GBX 747 ($10.11) per share, for a total transaction of £74,700 ($101,055.19).

The Biotech Growth Trust Stock Performance

Shares of BIOG traded up GBX 18 ($0.24) during trading hours on Friday, reaching GBX 762 ($10.31). 115,312 shares of the company traded hands, compared to its average volume of 171,689. The stock has a market capitalization of £217.69 million, a P/E ratio of 2.56 and a beta of 0.50. The company has a quick ratio of 0.00, a current ratio of 0.59 and a debt-to-equity ratio of 11.02. The Biotech Growth Trust PLC has a 12-month low of GBX 612.70 ($8.29) and a 12-month high of GBX 1,068.36 ($14.45). The business has a fifty day moving average price of GBX 707.89 and a 200-day moving average price of GBX 803.31.

About The Biotech Growth Trust

(Get Free Report)

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

See Also

Should You Invest $1,000 in The Biotech Growth Trust Right Now?

Before you consider The Biotech Growth Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Biotech Growth Trust wasn't on the list.

While The Biotech Growth Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines